.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
NIMHANS recently launched the CALM-Brain psychiatric repository. This groundbreaking initiative documents vital mental health data in India. The digital platform stores brain structure and function information across various disorders. Consequently, it marks a significant step toward personalized psychiatry in the country.
Researchers from the Rohini Nilekani Centre for Brain and Mind developed this system. Specifically, it focuses on five major conditions: addiction, bipolar disorder, dementia, OCD, and schizophrenia. Moreover, the dataset includes clinical, neuro-imaging, behavioral, and genetic data. This longitudinal approach allows clinicians to study disease progression over time. Additionally, practitioners can analyze these findings to provide better diagnoses and plan personalized treatments.
The initiative connects to a biorepository of stem cells. Thus, scientists can investigate the biological origins of severe mental illnesses. Furthermore, the repository currently holds data from over 2,000 participants from 900 families. Most global studies overlook South Asian populations. However, CALM-Brain addresses this gap by providing locally relevant data. Therefore, it will accelerate the discovery of effective therapeutic interventions.
Q1: What specific mental health disorders are included in the CALM-Brain repository?
The repository focuses on five major conditions: addiction, bipolar disorder, dementia, obsessive-compulsive disorder (OCD), and schizophrenia.
Q2: Who can access the CALM-Brain dataset for research purposes?
Clinicians and researchers aiming to study neuropsychiatric disorders can access this multi-modal dataset to understand disease onset and biological changes.
Q3: Why is the CALM-Brain project significant for Indian medical research?
It addresses the under-representation of South Asian data in global studies. Furthermore, it provides data on families rather than just individuals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NIMHANS launched CALM-Brain, India's first psychiatric data repository, focusing on five major disorders to improve diagnosis and personalized treatment....
6 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
